Emas Pharma

Bionical Emas is a specialist CRO combining Clinical Development, Early Access Programs and Clinical Trial Supply. Our Early Access Programs provide access to pre-approved medicines to help patients with unmet medical needs. Access is provided in response to physician requests, where no alternative treatment options are available, and the patient is not eligible for clinical trials for the condition.